Merkel Cell Carcinoma, Stage IV
1 clinical trials · Condition
◉ Watch Merkel Cell Carcinoma, Stage IV
| Record | Firm | Date |
|---|---|---|
| ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 (NCT07472322) | University of Wisconsin, Madison | 2026-08-01 |
Track Merkel Cell Carcinoma, Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.